PHERAstar measures AlphaScreen assay to develop selective inhibitors for the human YEATS domains

The PHERAstar^® FSX provides a powerful and versatile platform for drug discovery campaigns. This application note from BMG LABTECH describes a method for screening tens of thousands of compounds to identify small molecule inhibitors of human YEATS (Yaf9, ENL, AF9, Taf14, and Sas5) domains using an AlphaScreen^® approach.